Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study

Robert Wilson, Tobias Welte, Eva Polverino, Anthony De Soyza, Hugh Greville, Anne O'Donnell, Jeff Alder, Peter Reimnitz, Barbara Hampel
European Respiratory Journal 2013 41: 1107-1115; DOI: 10.1183/09031936.00071312
Robert Wilson
*Host Defence Unit, Royal Brompton Hospital, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: r.wilson@rbht.nhs.uk
Tobias Welte
#Hannover Medical School, Hannover
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Polverino
¶Hospital Clinic de Barcelona IDIBAPS, CIBERES, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony De Soyza
+Newcastle University and Freeman Hospital, Newcastle upon Tyne, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugh Greville
§Royal Adelaide Hospital, Adelaide, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne O'Donnell
fGeorgetown University Hospital, Washington, DC,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeff Alder
**Bayer HealthCare Pharmaceuticals Inc., Montville, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Reimnitz
##Bayer Pharma AG, Wuppertal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Hampel
¶¶Bayer Pharma AG, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 41 no. 5 1107-1115
DOI 
https://doi.org/10.1183/09031936.00071312
PubMed 
23018904

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received May 4, 2012
  • Accepted September 15, 2012
  • Published online April 30, 2013.

Article Versions

  • previous version (September 27, 2012 - 09:25).
  • previous version (October 11, 2012 - 10:22).
  • previous version (December 20, 2012 - 07:17).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©ERS 2013 ERJ Open articles are open access and distributed under the terms of the (Creative Commons Attribution Non-Commercial Licence 3.0)

Author Information

  1. Robert Wilson*⇑,
  2. Tobias Welte#,
  3. Eva Polverino¶,
  4. Anthony De Soyza+,
  5. Hugh Greville§,
  6. Anne O'Donnellf,
  7. Jeff Alder**,
  8. Peter Reimnitz## and
  9. Barbara Hampel¶¶
  1. *Host Defence Unit, Royal Brompton Hospital, London
  2. +Newcastle University and Freeman Hospital, Newcastle upon Tyne, UK
  3. #Hannover Medical School, Hannover
  4. ##Bayer Pharma AG, Wuppertal
  5. ¶¶Bayer Pharma AG, Berlin, Germany
  6. ¶Hospital Clinic de Barcelona IDIBAPS, CIBERES, Barcelona, Spain
  7. §Royal Adelaide Hospital, Adelaide, Australia
  8. fGeorgetown University Hospital, Washington, DC,
  9. **Bayer HealthCare Pharmaceuticals Inc., Montville, NJ, USA
  1. R. Wilson, Royal Brompton Hospital, London SW3 6NP, UK. E-mail: r.wilson{at}rbht.nhs.uk
View Full Text

Article usage

Article usage: September 2012 to May 2022

AbstractFullPdf
Sep 201259013
Oct 2012381080
Nov 2012132051
Dec 2012180042
Jan 2013313069
Feb 2013112045
Mar 20131040101
Apr 2013233561
May 20132905244535
Jun 2013100471128
Jul 20135573470
Aug 20131852771
Sep 20131171341
Oct 20131622359
Nov 20131022635
Dec 2013821826
Jan 20141021943
Feb 2014823238
Mar 20141083449
Apr 20141272744
May 2014791739
Jun 2014722029
Jul 20141163421
Aug 20141014137
Sep 20141022233
Oct 20141083236
Nov 2014813932
Dec 2014772028
Jan 2015733233
Feb 20151013137
Mar 2015905128
Apr 20151052436
May 2015783238
Jun 2015733737
Jul 2015952218
Aug 2015913241
Sep 2015383615
Oct 2015245457
Nov 2015165017
Dec 2015135536
Jan 2016173131
Feb 2016326327
Mar 2016285849
Apr 2016277849
May 2016324573
Jun 2016274756
Jul 2016188838
Aug 2016158041
Sep 2016348838
Oct 2016459674
Nov 20169012367
Dec 2016338532
Jan 20172212226
Feb 20171411923
Mar 20172011727
Apr 2017216214
May 2017365725
Jun 2017136925
Jul 2017248031
Aug 2017164810
Sep 2017268325
Oct 2017197523
Nov 20172311357
Dec 2017195012
Jan 2018135616
Feb 2018225517
Mar 2018215420
Apr 2018115826
May 2018136320
Jun 2018135418
Jul 201812338
Aug 20185264
Sep 2018143612
Oct 2018413729
Nov 201817369
Dec 2018132311
Jan 2019123712
Feb 2019124520
Mar 2019105226
Apr 201982928
May 2019424033
Jun 2019373121
Jul 2019445018
Aug 2019399629
Sep 20193525315
Oct 2019475211
Nov 2019415712
Dec 2019494324
Jan 2020454813
Feb 2020417514
Mar 2020164217
Apr 2020163411
May 202093616
Jun 202062918
Jul 202052312
Aug 202011295
Sep 2020252919
Oct 2020284022
Nov 2020152732
Dec 2020264713
Jan 2021113919
Feb 2021123122
Mar 2021172819
Apr 2021204415
May 2021194116
Jun 202110369
Jul 2021163215
Aug 2021153427
Sep 20217247
Oct 2021125328
Nov 202182821
Dec 2021512836
Jan 2022155026
Feb 2022132937
Mar 2022104521
Apr 2022192619
May 2022133834

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 41 Issue 5 Table of Contents
European Respiratory Journal: 41 (5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
Robert Wilson, Tobias Welte, Eva Polverino, Anthony De Soyza, Hugh Greville, Anne O'Donnell, Jeff Alder, Peter Reimnitz, Barbara Hampel
European Respiratory Journal May 2013, 41 (5) 1107-1115; DOI: 10.1183/09031936.00071312

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
Robert Wilson, Tobias Welte, Eva Polverino, Anthony De Soyza, Hugh Greville, Anne O'Donnell, Jeff Alder, Peter Reimnitz, Barbara Hampel
European Respiratory Journal May 2013, 41 (5) 1107-1115; DOI: 10.1183/09031936.00071312
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • CF and non-CF bronchiectasis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung volumes and survival in chronic lung allograft dysfunction
  • StO2 during weaning from mechanical ventilation
  • Automated quantification of radiological patterns predicts IPF survival
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society